Stemlab Advanced’s mission is to manufacture safe and innovative cell-based therapies for our customers. We are focused on delivering a GMP-compliant personalized solutions to overcome the development hurdles in the ATMPs field.
Our vision is to be a reliable development and manufacturing partner to all our clients (academic, clinical or SMEs) in early or late clinical development of the cell-based therapies.
Our GMP facility with three clean rooms is fully-equipped for the manufacturing of cell-based therapies. Our Analytical Laboratory and Cryopreservation facilities are also an asset for R&D studies.
We are located at Biocant Park, in the center of Portugal, within a 2-hour distance from the two major national airports.
Our team combines a long-time expertise on Production, Quality Control and Distribution of cell-based products with the knowledge and experience necessary for the development of innovative and sustainable ATMPs.
We apply all our skills to find the best solution for each product of our clients.
Company Details
- Founded
- 2022
- Address
- Biocant Park, Núcleo 04,lote 02,portugal
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.stemlabadvanced.pt/
- Keywords
- on Production.
- HQ
- Cantanhede
Stemlab Advanced Questions
Stemlab Advanced's website is https://www.stemlabadvanced.pt/
Stemlab Advanced's LinkedIn profile is https://pt.linkedin.com/company/stemlab-advanced
Stemlab Advanced's industry is
Biotechnology Research
Stemlab Advanced's top competitors are
Crioestaminal,
Y Farma,
Biotrend Sa,
Laboratório De Microbiologia Aplicada,
Carbocode,
Lmh Wines, Lda,
Fluidomica,
Immunethep,
Brt Blood Reprogramming Technologies Lda,
Exogenus Therapeutics.
Stemlab Advanced's categories are Biotechnology Research
Stemlab Advanced's founding year is 2022
